The Food and Drug Administration (FDA) is notifying the public about a proposed collection of information related to the extralabel use of drugs in animals that has been submitted to the Office of Management and Budget (OMB) for review. This request is part of the Paperwork Reduction Act of 1995 process. The proposal involves the FDA's ability to set safety levels for drug residues and require methods to detect them. Public comments on this collection of information can be submitted until February 12, 2021.
Simple Explanation
The FDA wants to collect information about how people use certain animal medicines in ways they are not originally meant for. They need help figuring out how to check that these medicines are safe, and they're asking people to share their thoughts by February 12, 2021.